Abstract
Purpose
To evaluate the surgical outcomes of patients with gallbladder cancer (GBC) with jaundice due to as-yet unelucidated prognostic factors.
Methods
A total of 348 GBC patients underwent resection at our institute between 1985 and 2016. Of these, 67 had jaundice (serum total bilirubin ≥ 2 mg/dL). Preoperative biliary drainage was performed, with portal vein embolization as required. All patients underwent radical surgery. We retrospectively evaluated the outcomes, performed multivariate analysis for overall survival, and compared our findings to those reported in the literature.
Results
The 5-year survival rate of M0 (no distant metastasis) GBC patients with jaundice, who underwent resectional surgery, was 21.9%, versus 68.3% in those without jaundice (p < 0.05). Since 2000, surgical mortality in GBC patients with jaundice has decreased from 12 to 6.8%. Patients with jaundice had more advanced disease and underwent major hepatectomies and vascular resections; however, preoperative jaundice alone was not a prognostic factor. Multivariate analysis of jaundiced patients revealed that percutaneous biliary drainage (PTBD) (vis-à-vis endoscopic drainage [EBD], hazard ratio [HR] 2.82), postoperative morbidity (Clavien–Dindo classification ≥ 3, HR 2.31), and distant metastasis (HR 1.85) were predictors of poor long-term survival. The 5-year survival and peritoneal recurrence rates in M0 patients with jaundice were 16% and 44%, respectively, for patients with PTBD and 39% (p < 0.05) and 13% (p = 0.07) for those with EBD.
Conclusion
M0 GBC patients with jaundice should undergo surgery if R0 resection is possible. Preoperative EBD may be superior to PTBD in M0 GBC patients with jaundice, although further studies are needed.
Similar content being viewed by others
Code availability
Not applicable
References
Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11:310–315
Dasari Bobby VM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ et al (2018) Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: a systematic review and meta-analysis. J Surg Oncol 118:477–485
Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Schmidt C, Beal EW, Hawkins WG, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA (2017) Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg 21:1245–1253
Redaelli CA, Buchler MW, Schilling MK, Krahenbuhl L, Ruchti C, Blumgart LH et al (1997) High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery. 121:58–63
Rau C, Marec F, Vibert E, Geslin G, Yzet T, Joly JP, Chatelain D, Duval H, Regimbeau JM (2004) Gallbladder cancer revealed by a jaundice caused by an endobiliary tumor thrombus. Ann Chir 129:368–371
Mishra PK, Saluja SS, Prithiviraj N, Varshney V, Goel N, Patil N (2017) Predictors of curative resection and long-term survival of gallbladder cancer – a retrospective analysis. Am J Surg 214:278–286. https://doi.org/10.1016/j.amjsurg.2017.02.006
Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Misuta K, Sekido H, Togo S (2003) Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg 27:1137–1142
Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y (2007) Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepato-Biliary-Pancreat Surg 14:351–357
Kobayashi A, Oda T, Fukunaga K, Sasaki R, Ohkohchi N (2012) Invasion of the hepatic artery is a crucial of poor outcomes in gallbladder carcinoma. World J Surg 36:645–650
Higuchi R, Ota T, Araida T, Kajiyama H, Yazawa T, Furukawa T (2014) Surgical approaches to advanced gallbladder cancer: a 40-year single-institution study of prognostic factors and reesectability. Ann Surg Oncol 21:4308–4316
Yamamoto Y, Sugiura T, Ashida R, Okamura Y, Ito T, Uesaka K (2017) Indications for major hepatectomy and combined procedures for advanced gallbladder cancer. Br J Surg 104:257–266
Higuchi R, Ota T, Yazawa T, Kajiyama H, Araida T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M (2016) Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today 46:74–83
Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Iasayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T (2015) Clinical Practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci 22:249–273
Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M (2019) Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases. J Hepatobiliary Pancreat Sci 26:490–502
Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M, Kokudo N, Sano K, Endo I, Unno M, Chijiiwa K, Horiguchi A, Kinoshita H, Oka M, Kubota K, Sugiyama M, Uemoto S, Shimada M, Suzuki Y, Inui K, Tazuma S, Furuse J, Yanagisawa A, Nakanuma Y, Kijima H, Takada T (2015) Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rd English edition. J Hepatobiliary Pancreat Sci 22:181–96. https://doi.org/10.1002/jhbp.211
Zhu AX, Pawlik TM, Kooby DA, Schefter TE, Vauthey JN (2017) Gallbladder. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK (eds) AJCC cancer staging manual. Springer, New York, pp 303–309
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196
Varma V, Gupta S, Soin AS, Nundy S (2009) Does the presence of jaundice and/or a lump in a patient with gall bladder cancer mean that the lesion is not resectable? Dig Surg 26:306–311
Miyazaki M, Itoh H, Ambiru S et al (1996) Radical surgery for advanced gallbladder carcinoma. Br J Surg 83:478–481
Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Yuasa N, Sano T, Hayakawa N (2003) Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg 27:272–277
Agarwal AK, Mandal S, Singh S, Bhojwani R, Sakhuja P, Uppal R (2007) Biliary obstruction in gall bladder cancer is not sine quanon of inoperability. Ann Surg Oncol 14:2831–2837
D’Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR (2009) Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 16:806–816
Nishio H, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M (2011) Gallbladder cancer involving the extrahepatic duct is worthy of resection. Ann Surg 253:953–960
Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F et al (2011) Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol 37:505–512
Yang XW, Yuan JM, Chen JY, Yang J, Gao QG, Yan XZ, Zhang BH, Feng S, Wu MC (2014) The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer 14:652
Nasu Y, Tanaka E, Hirano S, Tsuchikawa T, Kato K, Matsumoto J, Shichinohe T, Kondo S (2012) The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 19:274–280
Higuchi R, Yamamoto M (2014) Indications of portal vein embolization in perhilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:542–549
Nasu Y, Hirano S, Tsuchikawa T, Schichinohe T (2016) Aggressive surgery for locally advanced gallbladder cancer with obstructive jaundice: result of a prospective study. Dig Surg 33:213–219
Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L (2014) Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol 40:1008–1015
Fong Y, Janargin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232:557–569
Shih SP, Schulick RD, Cameron JL, Lillemoe KD, Pitt HA, Choti MA, Campbell KA, Yeo CJ, Talamini MA (2007) Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 245:893–901
Lopez-Aguiar AG, Ethun CG, McInnsis MR et al (2018) Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: a 10- institution study from the US Extrahepatic Biliary Malignancy Consortium. J Surg Oncol 117:1638–1647
Kawakami H, Kuwatani M, Eto K, Kudo T, Tanaka E, Hirano S (2012) Endoscopic nasobiliary drainage should be initially selected for preoperative biliary drainage in patients with perihilar bile duct cancer. World J Surg 36:2265–2266 author reply 2267-8
Higuchi R, Yazawa T, Uemura S, Izumo W, Chaudhary RJ, Furukawa T, Yamamoto M (2017) ENBD is associated with decreased tumor dissemination compared to PTBD in perihilar cholangiocarcinoma. J Gastrointest Surg 21:1506–1514
Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M (2017) Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery 161:394–404
Dixon E, Vollmer CM Jr, Sahajpal A, Cattral M, Grant D, Doig C, Hemming A, Taylor B, Langer B, Greig P, Gallinger S (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Centre. Ann Surg 241:385–394
Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372
Funding
This work was supported by the JSPS KAKENHI (grant number 18K08632).
Author information
Authors and Affiliations
Contributions
RKC, RH, and MY conceptualized the study design and wrote the article. TY, SU, WI, YM, EN, and TO helped with data collection and surgeries, along with RH, MY, and RKC. TF helped with pathology. YS provided advice on the statistics.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
This study was approved by the institutional review board of Tokyo Women’s Medical University (approval number: 4328-R). The study was a retrospective analysis of a prospectively maintained database. The procedures followed were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Consent to participate
The need for informed consent was waived because this was a retrospective chart review analysis.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Summary
In this study, we present our experience of over 40 years in managing patients with gallbladder cancer with jaundice who underwent resectional surgery. The importance of this article is that it focusses on identifying patients and practices that may result in long-term survival in these patients.
Supplementary information
Supplemental Table 1
Univariate and multivariate analyses of prognostic factors for overall survival in patients with gallbladder cancer (GBC) (DOCX 19 kb).
Supplemental Table 2
Background in M0 gallbladder cancer (GBC) patients with jaundice without surgical mortality depending on the type of drainage (DOCX 22 kb).
Supplemental Table 3
Postoperative recurrence in M0 gallbladder cancer (GBC) patients with jaundice excluding surgical mortality depending on the type of drainage (DOCX 16 kb).
Supplemental Table 4
Details of long-term survivors among patients with jaundice (DOCX 16 kb).
Supplementary Figure 1
Overall survival in patients with gallbladder cancer with jaundice depending on the time of the surgery (JPG 67 kb).
Supplementary Figure 2
Overall survival in M0 patients with gallbladder cancer with jaundice depending on the time of the surgery (JPG 72 kb).
Rights and permissions
About this article
Cite this article
Chaudhary, R.K., Higuchi, R., Yazawa, T. et al. Resectional surgery in gallbladder cancer with jaundice—how to improve the outcome?. Langenbecks Arch Surg 406, 791–800 (2021). https://doi.org/10.1007/s00423-020-02075-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-020-02075-8